DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,395 filers reported holding DANAHER CORPORATION in Q2 2019. The put-call ratio across all filers is 0.58 and the average weighting 0.7%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $20,906,045 | -17.0% | 84,268 | -19.7% | 0.38% | -11.5% |
| Q2 2023 | $25,186,833 | +25.0% | 104,954 | +31.3% | 0.43% | +29.6% |
| Q1 2023 | $20,146,302 | -89.6% | 79,944 | -89.1% | 0.34% | -90.5% |
| Q4 2022 | $194,584,415 | -7.1% | 733,107 | -9.6% | 3.51% | -21.9% |
| Q3 2022 | $209,431,000 | -7.9% | 810,818 | -9.6% | 4.50% | -6.5% |
| Q2 2022 | $227,293,000 | -4.1% | 896,553 | +11.0% | 4.81% | +25.7% |
| Q1 2022 | $236,925,000 | +6.2% | 807,695 | +19.1% | 3.83% | +22.6% |
| Q4 2021 | $223,173,000 | +1136.2% | 678,318 | +1043.9% | 3.12% | +1287.6% |
| Q3 2021 | $18,053,000 | +13.6% | 59,300 | +0.1% | 0.22% | +22.3% |
| Q2 2021 | $15,894,000 | +12.5% | 59,228 | -5.7% | 0.18% | +13.6% |
| Q1 2021 | $14,132,000 | +20.2% | 62,788 | +18.7% | 0.16% | +31.7% |
| Q4 2020 | $11,753,000 | +3.2% | 52,907 | 0.0% | 0.12% | -8.9% |
| Q3 2020 | $11,392,000 | +19.6% | 52,907 | -1.8% | 0.14% | +2.3% |
| Q2 2020 | $9,526,000 | +1208.5% | 53,871 | +923.8% | 0.13% | +1000.0% |
| Q1 2020 | $728,000 | -2.5% | 5,262 | +8.2% | 0.01% | +20.0% |
| Q4 2019 | $747,000 | +118.4% | 4,864 | +105.3% | 0.01% | +150.0% |
| Q3 2019 | $342,000 | +12.9% | 2,369 | +11.9% | 0.00% | 0.0% |
| Q2 2019 | $303,000 | – | 2,118 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |